Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

The man was diagnosed with lupus and improved with treatment.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Two newborns with rare skin infections were successfully treated with antifungal cream.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.